Elicio Therapeutics, Inc. (ELTX) stock forecast and price target
Price $1.50 · data as of November 13, 2026
12-month price target
Average target$13.00
Upside / downside+766.7%
Analysts3
ConsensusBuy
Low $8.00Average $13.00High $21.00
Gold marker: average target · white marker: today’s price ($1.50)
Analyst ratings
Strong buy 0Buy 2Hold 1Sell 0Strong sell 0
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends December 31, 2026 | $-1.68 | +34.8% | $0 |
| Next fiscal year ends December 31, 2027 | $-1.42 | +15.9% | $0 |
| Next quarter ends December 31, 2026 | $-0.35 | +29.2% | $0 |
| Quarter after ends March 31, 2027 | $-0.37 | +43.6% | $0 |
Consensus of the analysts covering Elicio Therapeutics, updated daily.
Frequently asked questions
What is the Elicio Therapeutics stock price target?
The average 12-month target from 3 analysts is $13.00, 766.7% above the current price of $1.50 Targets range from $8.00 to $21.00.
Is Elicio Therapeutics a buy according to analysts?
The consensus rating is “Buy” (2 buy, 1 hold). Ratings are opinions, not guarantees; this is not investment advice.
How much is Elicio Therapeutics expected to earn?
Analysts expect EPS of $-1.68 for the fiscal year ending December 31, 2026 and $-1.42 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.